Tycho Peterson
Stock Analyst at Jefferies
(5.00)
# 1
Out of 4,784 analysts
129
Total ratings
64.44%
Success rate
272.29%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Buy | $275 → $290 | $230.02 | +26.08% | 2 | Feb 6, 2025 | |
| DHR Danaher | Maintains: Buy | $285 → $260 | $205.85 | +26.31% | 1 | Jan 29, 2025 | |
| NEO NeoGenomics | Initiates: Buy | $22 | $9.62 | +128.69% | 1 | Dec 10, 2024 | |
| DGX Quest Diagnostics | Assumes: Buy | $185 | $167.33 | +10.56% | 1 | Dec 10, 2024 | |
| QDEL QuidelOrtho | Initiates: Hold | $43 | $34.89 | +23.24% | 5 | Dec 10, 2024 | |
| HOLX Hologic | Initiates: Hold | $85 | $61.32 | +38.62% | 7 | Dec 10, 2024 | |
| QGEN Qiagen | Assumes: Buy | $43 → $56 | $39.85 | +39.57% | 5 | Dec 10, 2024 | |
| WAT Waters | Upgrades: Buy | $355 → $415 | $362.16 | +14.59% | 7 | Oct 8, 2024 | |
| TWST Twist Bioscience | Maintains: Underweight | $28 → $35 | $40.36 | -13.28% | 3 | Aug 5, 2024 | |
| RVTY Revvity | Maintains: Hold | $115 → $125 | $105.62 | +18.35% | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $9.16 | +162.01% | 7 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.14 | +250.88% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $0.89 | +238.03% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $143.94 | -1.35% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $43.14 | -25.82% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $80.00 | +43.75% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $8.88 | +125.23% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $500.16 | +29.96% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $1,230 → $1,250 | $1,177.09 | +6.19% | 7 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $11.77 | -23.53% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.68 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $1.74 | +589.66% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $6.56 | +814.63% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $3.26 | +605.52% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $155.55 | +150.72% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $150 | $116.69 | +28.55% | 7 | May 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $1.43 | +1,508.39% | 1 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $3.43 | +424.78% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $491.84 | -59.34% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $16.97 | +41.43% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $14.93 | +201.41% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $160 | $0.70 | +22,757.14% | 4 | Sep 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $133.41 | -47.53% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $177.39 | -32.35% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $1.82 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $42.08 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $15.11 | +264.00% | 1 | Jul 19, 2016 |
Labcorp Holdings
Feb 6, 2025
Maintains: Buy
Price Target: $275 → $290
Current: $230.02
Upside: +26.08%
Danaher
Jan 29, 2025
Maintains: Buy
Price Target: $285 → $260
Current: $205.85
Upside: +26.31%
NeoGenomics
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $9.62
Upside: +128.69%
Quest Diagnostics
Dec 10, 2024
Assumes: Buy
Price Target: $185
Current: $167.33
Upside: +10.56%
QuidelOrtho
Dec 10, 2024
Initiates: Hold
Price Target: $43
Current: $34.89
Upside: +23.24%
Hologic
Dec 10, 2024
Initiates: Hold
Price Target: $85
Current: $61.32
Upside: +38.62%
Qiagen
Dec 10, 2024
Assumes: Buy
Price Target: $43 → $56
Current: $39.85
Upside: +39.57%
Waters
Oct 8, 2024
Upgrades: Buy
Price Target: $355 → $415
Current: $362.16
Upside: +14.59%
Twist Bioscience
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $40.36
Upside: -13.28%
Revvity
Jul 29, 2024
Maintains: Hold
Price Target: $115 → $125
Current: $105.62
Upside: +18.35%
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $9.16
Upside: +162.01%
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $1.14
Upside: +250.88%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $0.89
Upside: +238.03%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $143.94
Upside: -1.35%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $43.14
Upside: -25.82%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $80.00
Upside: +43.75%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $8.88
Upside: +125.23%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $500.16
Upside: +29.96%
Jun 3, 2024
Assumes: Underperform
Price Target: $1,230 → $1,250
Current: $1,177.09
Upside: +6.19%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $11.77
Upside: -23.53%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $2.68
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $1.74
Upside: +589.66%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $6.56
Upside: +814.63%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $3.26
Upside: +605.52%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $155.55
Upside: +150.72%
May 26, 2021
Maintains: Overweight
Price Target: $140 → $150
Current: $116.69
Upside: +28.55%
May 11, 2021
Initiates: Overweight
Price Target: $23
Current: $1.43
Upside: +1,508.39%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $3.43
Upside: +424.78%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $491.84
Upside: -59.34%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $16.97
Upside: +41.43%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $14.93
Upside: +201.41%
Sep 27, 2019
Downgrades: Underweight
Price Target: $160
Current: $0.70
Upside: +22,757.14%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $133.41
Upside: -47.53%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $177.39
Upside: -32.35%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $1.82
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $42.08
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $15.11
Upside: +264.00%